Medical/Pharmaceuticals
HKSH Cancer Centre's Precision Targeting Technologies Leading the Evolution of "Hypofractionation"
Asia's First Study: 5 Sessions of Proton Therapy to Control Early-Stage Prostate Cancer HONG KONG, March 20, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) today announced the results of Asia's first clinical study on early-stage prostate cancer patients receiving five-session of proton therapy....
2026-03-20 19:10
4510
Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability
SHANGHAI and HONG KONG, March 20, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced its full-year results for the period ending December 31, 2025, and provided an update on recent business highlights and strategic progress. Dr. Jay Mei, Antengene's...
2026-03-20 17:14
7067
World Oral Health Day 2026: FDI urges governments to turn UN oral health commitments into action
Landmark UN political declaration recognizes oral health as essential to
tackling noncommunicable diseases
GENEVA, March 20, 2026 /PRNewswire/ -- On World Oral Health Day
2026-03-20 16:30
3580
Ribo expands beyond the liver with RiboPepSTAR™ - enabling targeted siRNA delivery to multiple organs
SUZHOU, China and MÖLNDAL, Sweden, March 20, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ("Ribo" or "the Company", Hong Kong Stock Exchange code: 6938) had been invited to give a speech at the RNA Leaders Europe Conference in Vienna, Austria on March 19th, one of the top oligonucleot...
2026-03-20 14:44
4482
MGI Tech and NUS Pharmacy and Pharmaceutical Sciences Announce Collaboration on DCS Lab to Accelerate Multi-Omics Innovation in Pharmaceutical Sciences
SINGAPORE, March 20, 2026 /PRNewswire/ -- MGI Tech Singapore Pte. Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and the Department of Pharmacy and Pharmaceutical Sciences in the National University of Singapore's Faculty of Sci...
2026-03-20 11:17
5181
Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Triple-Negative Breast Cancer of TROP2/HER3 Bispecific ADC JSKN016
SUZHOU, China, March 20, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating JSKN016, a novel TROP2/HER3 bispecific antibody-drug conjugate (ADC) for the treatment of triple-negat...
2026-03-20 10:04
3464
D3 Bio to Showcase Its Innovative KRAS Pipeline at AACR 2026, Including an Oral Presentation at Clinical Plenary Session
SHANGHAI, March 20, 2026 /PRNewswire/ -- D3 Bio Inc, a global clinical-stage biotechnology company focused on developing transformative oncology therapeutics, is pleased to announce that five abstracts have been accepted for presentation at the upcoming American Association for Cancer Research (A...
2026-03-20 09:00
4882
Crescel Reports Positive Randomized Controlled Trial Results for Biobotanical Skin Renewal Cream in Rosacea
Study Shows Greater Clinical Improvement vs. Metronidazole-Based Standard of Care with Favorable Tolerability MIAMI BEACH, Fla., March 20, 2026 /PRNewswire/ -- Crescel LLC, an innovative science and technology company, today announced results from a double-blind, randomized, active comparator-c...
2026-03-20 05:39
3425
ACOH 2026 Early Bird Rate Ends 30 April; Abstract Submission Closes 1 April
KUCHING, Malaysia, March 19, 2026 /PRNewswire/ -- Asia's leading platform on workplace health and safety, the 24th Asian Congress on Occupational Health (ACOH) 2026, is calling on researchers, practitioners, and industry professionals to secure their participation as key deadlines approach. Sche...
2026-03-19 19:26
3751
Brii Biosciences Provides Corporate Updates and Reports Full Year 2025 Financial Results
Advancing HBV Functional Cure Toward Key Phase 2b Data Readouts Increasing Discovery Efforts to Drive Long-term Value Creation Strong Cash Position Supporting Strategic Priorities Upcoming Conference Calls: English Session: March 20 at 8:30 p.m. HKT / 8:30 a.m. ET Chinese Session: March 20 at ...
2026-03-19 19:00
6072
Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China
SHANGHAI, March 19, 2026 /PRNewswire/ -- Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical Administration Bureau of Macao Special Administrative Region of China for the treatment of adult patie...
2026-03-19 18:27
3691
Infinitus Showcases Innovations at FHE2026, demonstrating supportive role of complex Polysaccharides on immune health
GUANGZHOU, China, March 18, 2026 /PRNewswire/ -- Infinitus (China) Company Ltd., a company with more than three decades in the traditional Chinese herbal health industry, was invited to participate in the Boao Food for Health Science Conference and Expo (FHE) 2026. During the event held at the Bo...
2026-03-19 09:41
4039
Kelun-Biotech to Present the Final OS Analysis of Sacituzumab Tirumotecan (Sac-TMT) from the OptiTROP-Lung03 Study
CHENGDU, China, March 18, 2026 /PRNewswire/ -- The 2026 European Lung Cancer Congress (ELCC) will be held in Copenhagen, Denmark, from March 25 to 28, 2026 (local time). At this congress, the final OS analysis from the pivotal study (OptiTROP-Lung03) of sacituzumab tirumotecan (sac-TMT, also know...
2026-03-18 22:31
6939
Picarro Launches PI2124 Hydrogen Peroxide Analyzer to Improve VHP Monitoring in Pharmaceutical Manufacturing
Software enhancements strengthen compliance support with better traceability,
audit readiness, and operational efficiency
SANTA CLARA, Calif., March 18, 2026 /PRNewswire/ -- Picarro Inc.
2026-03-18 22:10
4821
Alphamab Oncology Appoints Mr. Fei Wang as Chief Financial Officer
SUZHOU, China, March 18, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced the appointment of Mr. Fei Wang as Chief Financial Officer (CFO). Mr. Wang will be responsible for the company's capital operations, investment and financing management and investor relations, an...
2026-03-18 21:43
4747
Avid Organics to Launch the World's First Commercial-Scale Bio-Based Glycolic Acid, AviGa™ Bio HP70, at in-cosmetics® Global in Paris
* AviGa™ Bio HP70 is a bio-based, 70% cosmetic-grade glycolic acid available globally from April 14, 2026, with REACH registration ensuring uninterrupted European supply * The launch marks a pivotal shift for personal care, cosmetics, and pharmaceutical industries by offering a sustainable, t...
2026-03-18 17:27
4660
Basecamp Research Launches Trillion Gene Atlas to Scale AI-Designed Therapeutics
* The Atlas will expand known evolutionary genetic diversity by 100x, collecting novel genomic data from over 100 million new species across thousands of sites globally. * By partnering with Anthropic, Ultima Genomics, and PacBio, and powered by NVIDIA AI infrastructure, Basecamp Research aim...
2026-03-18 17:00
3242
ProtectHealth strengthen PeKa b40 health screening promotion with Hospital Shah Alam staff in Program Ziarah MADANI
SHAH ALAM, Malaysia, March 18, 2026 /PRNewswire/ -- ProtectHealth Corporation Sdn. Bhd., as an implementing agency under the Ministry of Health Malaysia (MOH), continues to strengthen efforts to promote the Skim Peduli Kesihatan for the B40 group during the Program Ziarah MADANI at Hospital Shah ...
2026-03-18 14:26
3459
Innodisk at NVIDIA GTC 2026: Accelerating Real-World AI for Healthcare and Mobility with Full-Stack Edge Solutions
SAN JOSE, Calif., March 18, 2026 /PRNewswire/ -- Innodisk, a leading global AI solution provider, today announced its participation in NVIDIA GTC 2026. Alongside subsidiary Aetina, Innodisk Group is showcasing the seamless integration of NVIDIA AI architectures into scalable, deployable edge AI ...
2026-03-18 11:32
4609
Everest Medicines Enters into Letter of Intent with Hasten Biopharmaceuticals (Asia) Limited
SHANGHAI, March 18, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into a letter of...
2026-03-18 11:07
8070
Week's Top Stories
Most Reposted
Agoda Opens New Office at One Bangkok, Enhancing Its Technology Hub in Thailand
[Picked up by 321 media titles]
2026-04-09 13:00
Visa Opens the Door to AI-Driven Shopping for Businesses Worldwide
[Picked up by 312 media titles]
2026-04-09 09:00Tata Power Collaborates with Databricks to Build Future-Ready Data and AI Platform to Accelerate Energy Transition
[Picked up by 302 media titles]
2026-04-10 11:13
iQIYI to Open Its First Central China Theme Park in Wuhan, Continuing to Bring IP Value Beyond the Screen
[Picked up by 288 media titles]
2026-04-10 11:38
OneQode, Hitachi Vantara & Cylix Form Strategic Alliance to Launch Sovereign AI Factory Initiative
[Picked up by 284 media titles]
2026-04-08 08:00
Most Read
Agoda Opens New Office at One Bangkok, Enhancing Its Technology Hub in Thailand
2026-04-09 13:00
7614
NYSE Content Update: Starfish Space Adds Over $100 Million in Funding to Boost Growth
2026-04-07 21:06
7394
Visa Opens the Door to AI-Driven Shopping for Businesses Worldwide
2026-04-09 09:00
7085